|
Volumn 5, Issue 7, 2009, Pages 941-944
|
New perspectives in cancer immunotherapy and immunomonitoring
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA 2 MICROGLOBULIN;
BIOLOGICAL MARKER;
CPG OLIGODEOXYNUCLEOTIDE;
CYCLOPHOSPHAMIDE;
CYTOKINE;
DENDRITIC CELL VACCINE;
DNA VACCINE;
HEAT SHOCK PROTEIN;
INTERLEUKIN 10 ANTIBODY;
PEPTIDE DERIVATIVE;
TUMOR MARKER;
CANCER VACCINE;
ADOPTIVE TRANSFER;
ANGIOGENESIS;
BRAIN TUMOR;
CANCER IMMUNIZATION;
CANCER IMMUNOTHERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DENDRITIC CELL;
DISEASE MODEL;
DRUG EFFICACY;
HEMATOLOGIC MALIGNANCY;
HUMAN;
IMMUNOLOGICAL MONITORING;
IMMUNOREGULATION;
IMMUNOSUPPRESSIVE TREATMENT;
LEUKEMIA;
LOW DRUG DOSE;
LUNG CANCER;
MELANOMA;
MOLECULAR MECHANICS;
MULTIPLE MYELOMA;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATE CARCINOMA;
REGULATORY T LYMPHOCYTE;
SOLID TUMOR;
T LYMPHOCYTE;
TUMOR GROWTH;
TUMOR IMMUNITY;
IMMUNOLOGY;
IMMUNOTHERAPY;
NEOPLASM;
REVIEW;
CANCER VACCINES;
HUMANS;
IMMUNOTHERAPY;
MONITORING, IMMUNOLOGIC;
NEOPLASMS;
|
EID: 73349120981
PISSN: 14796694
EISSN: 17448301
Source Type: Journal
DOI: 10.2217/fon.09.62 Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|